Synthesis and anti-platelet activity of obovatol derivatives

Archives of Pharmacal Research

Volumn 34, Issue 7, 2011, Pages 1107-1112

  Kwak, Jae Hwan ^a   Lee, Seul ^b   Park, Eun Seok ^a   In, Jin Kyung ^a   Song, Jiho ^b   Kim, Young Jin ^b   Choi, Nam Song ^c   Lee, Heesoon ^a   Yun, Yeo Pyo ^a   Hong, Jin Tae ^a   Kwak, Young Shin ^d   Min, Kyung Hoon ^b   Jung, Jae Kyung ^a  

^a Chungbuk National University   (South Korea)

^b Chung Ang University   (South Korea)

^c Botanical Drug Research Team Huons Co Ltd   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Anti platelet activity; Derivatives; Obovatol; Small molecules

Indexed keywords

3,4 DIMETHOX 5 (4 PROPOXYPHENOXY)BENZOIC ACID; ALLYL 3,4 DIMETHOXY 5 (4 PROPOXYPHENOXY)BENZOATE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; BENZYL 3,4 DIMETHOXY 5 (4 PROPOXYPHENOXY)BENZOATE; BUTYL 3,4 DIMETHOXY 5 (4 PROPOXYPHENOXY)BENZOATE; METHYL 3 (4 CYANOPHENOXY) 4,5 DIMETHOXYBENZOATE; METHYL 3 (4 ETHOXYPHENOXY) 4,5 DIMETHOXYBENZOATE; METHYL 3 HYDROXY 4,5 DIMETHOXYBENZOATE; METHYL 3,4 DIMETHOXY 5 (4 PROPOXYPHENOXY)BENZOATE; METHYL 3,4 DIMETHOXY 5 (4 VINYLPHENOXY)BENZOATE; OBOVATOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; INHIBITION KINETICS; NONHUMAN; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION;

ALCOHOLS; ANIMALS; ANTINEOPLASTIC AGENTS; ARACHIDONIC ACID; BIPHENYL COMPOUNDS; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; PHENYL ETHERS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RABBITS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80052342331     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0708-9     Document Type: Article

References (13)

1. D. H. Cowan 1981 Platelet adherence to collagen: Role of prostaglandin-thromboxane synthesis Br. J. Haematol. 49 425 434 6794597 10.1111/j.1365-2141.1981.tb07245.x 1:CAS:528:DyaL38XlslY%3D (Pubitemid 11027837)
2. 2 is increased in type IIA hypercholesterolemic subjects Atherosclerosis 60 61 66 3085686 10.1016/0021-9150(86)90088-2 1:CAS:528:DyaL28XitVCqtLg%3D (Pubitemid 16132793)
3. S. P. Jackson S. M. Schoenwaelder 2003 Antiplatelet therapy: in search of the 'magic bullet' Nat. Rev. Drug Discov. 2 775 789 14526381 10.1038/nrd1198 1:CAS:528:DC%2BD3sXnslarsb8%3D (Pubitemid 37361810)
4. Y. R. Jin J. H. Im E. S. Park M. R. Cho X. H. Han J. J. Lee Y. Lim T. J. Kim Y. P. Yun 2008 Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCγ2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity J. Cardiovasc. Pharmacol. 51 45 54 18209568 10.1097/FJC.0b013e31815ab4b6 1:CAS:528:DC%2BD1cXotlWntg%3D%3D
5. J. H. Kwak J. K. In M. S. Lee J. Y. Yu Y. P. Yun J. T. Hong S. J. Lee S. Y. Seo S. K. Ahn Y. G. Suh B. Y. Hwang H. Lee K. H. Min J. K. Jung 2009 Methyl aryloxy gallates as regulators of vascular smooth muscle cell proliferation Bull. Korean Chem. Soc. 30 2881 2882 10.5012/bkcs.2009.30.12.2881 1:CAS:528:DC%2BC3cXis1KisA%3D%3D
6. M. S. Lee J. E. Yang E. H. Choi J. K. In S. Y. Lee H. Lee J. T. Hong H. W. Lee Y. G. Suh J. K. Jung 2007 Synthesis of obovatol derivatives and their preliminary evaluation as antitumor agents Bull. Korean Chem. Soc. 28 1601 1604 10.5012/bkcs.2007.28.9.1601 1:CAS:528:DC%2BD2sXhsValu7nP (Pubitemid 47510175)
7. S. Y. Lee J. S. Cho D. Y. Yuk D. C. Moon J. K. Jung H. S. Yoo Y. M. Lee S. B. Han K. W. Oh J. T. Hong 2009 Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-κB J. Pharmacol. Sci. 111 124 136 19834284 10.1254/jphs.09048FP 1:CAS:528:DC%2BD1MXhtlKntLrO
8. Y. Lim J. S. Kwon D. W. Kim S. H. Lee R. K. Park J. J. Lee J. T. Hong H. S. Yoo B. M. Kwon Y. P. Yun 2010 Obovatol from Magnolia obovata inhibits vascular smooth muscle cell proliferation and intimal hyperplasia by inducing p21Cip1 Atherosclerosis 210 372 380 20022323 10.1016/j.atherosclerosis.2009.11. 037 1:CAS:528:DC%2BC3cXmslGnu7k%3D
9. A. D. Michelson 2010 Antiplatelet therapies for the treatment of cardiovascular disease Nat. Rev. Drug Discov. 9 154 169 20118963 10.1038/nrd2957 1:CAS:528:DC%2BC3cXht1yns7c%3D
10. 3H]arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen Biochem. J. 235 869 877 3092807 1:CAS:528:DyaL28XitVCmt7w%3D (Pubitemid 16072000)
11. M. K. Pyo Y. Lee H. S. Yun-Choi 2002 Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata Arch. Pharm. Res. 25 325 328 12135105 10.1007/BF02976634 1:CAS:528:DC%2BD38Xlt1egsLk%3D
12. S. Willoughby A. Holmes J. Loscalzo 2002 Platelets and cardiovascular disease Eur. J. Cardiovasc. Nurs. 1 273 288 14622657 10.1016/S1474-5151(02) 00038-5 (Pubitemid 36857068)
13. J. Y. Yu J. J. Lee J. K. Jung T. J. Kim H. S. Yoo Y. P. Yun J. C. Lee 2009 JY0691, a newly synthesized obovatol derivative, inhibits cell cycle progression of rat aortic smooth muscle cells through up-regulation of p21(cip1) Eur. J. Pharmacol. 624 23 30 19819237 10.1016/j.ejphar.2009.09.061 1:CAS:528:DC%2BD1MXhtlyhtbnK